Brittany Ciaramello
Podiatrist · Joplin, MONPI 1104288141
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (43.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Arthrex at 40.4% of the total. Reporting peaked in 2022 at $3,557 and has fallen 93.9% since, to $219 in 2025.
Across 52 payments — averaging $96.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Titan Surgical Group, LLC$2K
- Smith+Nephew$398
- Medtronic$341
- Gramercy Extremity Orthopedics LLC$267
- Kerecis Limited$61
- plus $388 from 15 others
What the payments were for
- Travel & lodging$2,17943%
- Food & beverage$1,63333%
- Education$1,20024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 13 | $2,025 |
| Titan Surgical Group, LLC | 2 | $1,532 |
| Smith+Nephew | 9 | $398 |
| Medtronic | 5 | $341 |
| Gramercy Extremity Orthopedics LLC | 1 | $267 |
| Kerecis Limited | 3 | $61 |
| Globus Medical | 3 | $52 |
| Organogenesis Inc. | 2 | $44 |
| Angiodynamics, Inc. | 1 | $43 |
| Nevro Corp. | 2 | $39 |
| Stryker | 1 | $26 |
| Hydrofera LLC | 1 | $24 |
| Convatec Inc. | 1 | $22 |
| Urgo Medical North America, LLC | 1 | $22 |
| Averitas Pharma Inc. | 1 | $21 |
| Reprise Biomedical, Inc. | 1 | $19 |
| Seapearl East, Inc | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $15 |
| Melinta Therapeutics, LLC | 1 | $13 |
| Advanced Oxygen Therapy Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$265
- GRAFIX PL$126
- ClosureFast$106
How this compares
$5,012 in reported general payments places this provider in the 80th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 92 | $2,229 |
| Gabapentin | 48 | $678 |
| Ammonium Lactate | 39 | $459 |
| Mupirocin | 39 | $228 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 34 | $156 |
| Allopurinol | 12 | $144 |
| Clindamycin Hcl | 17 | $141 |
| Methylprednisolone | 14 | $105 |
| Cefadroxil | 13 | $85 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Joplin
- Erick StudyvinJoplin$7K
- William DukeJefferson City$54K
- Kiera Benge-SheaSaint Louis$28K
- Thomas BoldryLiberty$19K
- Ryan FrankIndependence$15K
- Neil ErmitanoSaint Louis$14K
- John HarnessOverland$14K
- Brittany StaplesCreve Coeur$13K
- Daniel NarowitzSaint Louis$12K
- Jay MoradiaSaint Louis$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.